Author

Ruifan Dai

Institution: Moffitt Cancer Center

Observed institution: Moffitt Cancer Center

ORCID: 0009-0004-3626-614X

Observed ORCID: 0009-0004-3626-614X

OpenAlex ID: A5075730580

SMAD4 Deficiency Promotes Pancreatic Cancer Progression and Confers Susceptibility to TGFβ Inhibition

2025 · Gilbert Z. Murimwa, Natalie E. Williams, et al. · Cancer Research · 12

Translational relevance of SOS1 targeting for KRAS‐mutant colorectal cancer

2023 · Diego Alem, Xinrui Yang, et al. · Molecular Carcinogenesis · 9

Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma

2023 · Dae Won Kim, Francisca Beato, et al. · Oncotarget · 3

Abstract B032: KRAS copy number variation and mutant allele fractions predict in vitro response of PDX-derived human pancreatic cancer cell lines to KRASG12D inhibitor MRTX1133

2023 · Bhaswati Sarcar, Alexandra Tassielli, et al. · Molecular Cancer Research · 1

The translational role of SOS1 in colorectal cancer

2022 · Diego Alem, Xinrui Yang, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1

Ratiometric Fluorescent Chemosensing for Predicting Response to Irinotecan-Based Therapies in Pancreatic Ductal Adenocarcinoma

2026 · Karishma Kailass, Alexandra F. Tassielli, et al. · ACS Sensors

Supplementary Figure 6 from SMAD4 Deficiency Promotes Pancreatic Cancer Progression and Confers Susceptibility to TGFβ Inhibition

2025 · Gilbert Z. Murimwa, Natalie E. Williams, et al.

Supplementary Figure 1 from SMAD4 Deficiency Promotes Pancreatic Cancer Progression and Confers Susceptibility to TGFβ Inhibition

2025 · Gilbert Z. Murimwa, Natalie E. Williams, et al.

Supplementary Figure 5 from SMAD4 Deficiency Promotes Pancreatic Cancer Progression and Confers Susceptibility to TGFβ Inhibition

2025 · Gilbert Z. Murimwa, Natalie E. Williams, et al.

Supplementary Figure 4 from SMAD4 Deficiency Promotes Pancreatic Cancer Progression and Confers Susceptibility to TGFβ Inhibition

2025 · Gilbert Z. Murimwa, Natalie E. Williams, et al.

Supplementary Figure 2 from SMAD4 Deficiency Promotes Pancreatic Cancer Progression and Confers Susceptibility to TGFβ Inhibition

2025 · Gilbert Z. Murimwa, Natalie E. Williams, et al.

Supplementary Figure 7 from SMAD4 Deficiency Promotes Pancreatic Cancer Progression and Confers Susceptibility to TGFβ Inhibition

2025 · Gilbert Z. Murimwa, Natalie E. Williams, et al.

Supplementary Figure 3 from SMAD4 Deficiency Promotes Pancreatic Cancer Progression and Confers Susceptibility to TGFβ Inhibition

2025 · Gilbert Z. Murimwa, Natalie E. Williams, et al.

Supplementary Table 1 from SMAD4 Deficiency Promotes Pancreatic Cancer Progression and Confers Susceptibility to TGFβ Inhibition

2025 · Gilbert Z. Murimwa, Natalie E. Williams, et al.

Data from SMAD4 Deficiency Promotes Pancreatic Cancer Progression and Confers Susceptibility to TGFβ Inhibition

2025 · Gilbert Z. Murimwa, Natalie E. Williams, et al.

Building research infrastructure to advance precision medicine in colorectal cancer

2025 · Stephanie L Schmit, Nicole C Loroña, et al. · JNCI Cancer Spectrum

Correction: Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma

2024 · Dae Won Kim, Francisca Beato, et al. · Oncotarget

Works count: 17

Citation count: 26

H-index: 3

I10-index: 1